MYCN and neuroblastoma: Age, tumor stage, mitosis-karyorrhexis index (MKI), MYCN amplification, and ALK expression are used to predict the clinical outcomes of NB (Perel et al., 2004; Chang et al., 2020; Sokol et al., 2020).